ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.238,36
1,67%
S&P 500
5.746,15
0,42%
Dow Jones
42.205,28
0,69%
Euro vs US Dollar
1,11806
0,43%
Bitcoin
65.306,46
3,44%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) News

IGMS

IGM Biosciences (IGMS)

IGM Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IGMS
DatumZeitQuelleÜberschriftSymbolFirma
18/09/202402h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
18/09/202402h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
18/09/202402h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
18/09/202402h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
18/09/202402h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
18/09/202402h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
18/09/202402h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
10/09/202422h05GlobeNewswire Inc.IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation SummitNASDAQ:IGMSIGM Biosciences Inc
14/08/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
14/08/202413h00GlobeNewswire Inc.IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
14/08/202412h50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IGMSIGM Biosciences Inc
13/08/202402h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
03/08/202400h41Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IGMSIGM Biosciences Inc
29/07/202423h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
25/07/202419h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IGMSIGM Biosciences Inc
24/07/202402h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
24/07/202402h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
24/07/202402h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
24/07/202402h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
24/07/202402h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
20/06/202412h06Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:IGMSIGM Biosciences Inc
19/06/202401h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202401h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202401h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202401h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202401h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202401h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
19/06/202401h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
18/06/202423h00Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:IGMSIGM Biosciences Inc
14/06/202414h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:IGMS

Kürzlich von Ihnen besucht

EU
PIWEG
Euronext Positive Impact...
BIT
P1VUZ2
NLBNPIT1VUZ2 20991231 72...
TG
HOJ
Horizon Oil
TG
V71
Hut 8
LSE
SU76
Euro.bk 25
TSXV
CQV.H
Canadian Imperial Venture
LSE
95KC
Imp.br.fin.26 S
BIT
1NOC
Northrop Grumman
CXIO
BANDUSD
BandToken
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten